Skip to content
Search

Latest Stories

PSNC expects negotiations with government for CPCF 2022-23 to begin soon

Pharmaceutical Services Negotiating Committee (PSNC) expects the next round of negotiations to set the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2022/23 – Year 4 of the five-year CPCF deal, to begin soon.

The negotiator held a meeting on November 24 and 25 to discuss the burning issues affecting the sector and to plan for upcoming negotiations with the Department of Health and Social Care (DHSC) and NHS England and NHS Improvement (NHSE&I).


It aims to complete these negotiations by April, allowing ample time for contractors to make arrangement prior to the beginning of the financial year.

PSNC vice-chair, and independent contractor, Bharat Patel said the entire sector is worried about the “outlook for pharmacies as we head into a difficult winter,” and is working to find solutions.

He noted that PSNC “will be bringing proposals for additional funding and support, particularly around the treatment of ‘walk-in’ patients, to the table, along with a heavy dose of realism for government and the NHS about the current challenges in the sector.”

While expecting a difficult round of discussion with the government, Patel remained optimistic about a favourable outcome for pharmacies.

Key issues discussed in the recent meeting included:

Workforce

PSNC members expressed concerns over contractors’ struggle to recruit staff and pharmacists, and reported a steep rise in their wages bill. They noted that some pharmacies have also been forced to close due to workforce crisis.

This is expected to be a critical topic in the upcoming negotiations.

Funding

Members acknowledged that the ongoing funding squeeze is putting unsustainable pressure on pharmacy businesses. Therefore, despite the rejection of earlier bid for an uplift to the CPCF funding, PSNC will raise this issue again and “will consider how best to do this”.

Capacity issues

PSNC expressed its frustration as the “work that was supposed to help pharmacies to free up capacity through the five-year CPCF deal has not yet been delivered.”

The committee analysed possible ways to help pharmacies to free up capacity.

Increased walk-ins

With an increased number of people walking into pharmacies seeking advice on minor conditions or with their existing health conditions, PSNC views that these ‘walk-ins’ must be fully funded.

The negotiator said that it would make “the case for this as part of the upcoming negotiations.”

Other topics of discussions included Annual Review of the CPCF on which more information is expected soon.

The committee also heard the latest Review Steering Group thinking about the future of both national and local community pharmacy representation.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less